Sara Ebel, PA
Physician Assistant · Pinehurst, NCNPI 1750693289
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,716 of the $21,637 with a category attached, or 72.6%. 42 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 27.1% of the total. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 691 payments — averaging $31.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$6K
- Sanofi$3K
- AstraZeneca$2K
- GSK$2K
- Grifols USA, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$922
- plus $7K from 36 others
What the payments were for
- Consulting fees$4,43821%
- Travel & lodging$1,0135%
- Food & beverage$15,71673%
- Education$4712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,637 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 65 | $824,747 |
| OfevNintedanib Esylate | 38 | $498,059 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 621 | $467,639 |
| AdempasRiociguat | 34 | $434,377 |
| Orenitram ErTreprostinil Diolamine | 33 | $431,167 |
| UptraviSelexipag | 12 | $279,273 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 297 | $233,050 |
| NucalaMepolizumab | 49 | $178,894 |
| Dupixent PenDupilumab | 25 | $93,386 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 160 | $89,894 |
| Dupixent SyringeDupilumab | 22 | $88,189 |
| Breo ElliptaFluticasone/Vilanterol | 149 | $82,420 |
| Fasenra PenBenralizumab | 13 | $81,120 |
| TezspireTezepelumab-Ekko | 14 | $63,246 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 83 | $38,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Opsumit, Uptravi | $5,855 | $1,104,02077 claims |
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,957 | $794,176981 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $884 | $618,608255 claims |
| BayerAdempas | $29 | $434,37734 claims |
| AstraZenecaBreztri Aerosphere, Tezspire, Symbicort, Bevespi Aerosphere | $2,268 | $339,144459 claims |
| MerckBelsomra, Dulera | $322 | $12,89732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Pinehurst
- Robert ThomasPinehurst$60K
- Grant BischofPinehurst$25K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.